Upadacitinib for the Treatment of Alopecia Areata and Severe Atopic Dermatitis in a Pediatric Patient: A Case Report

January 2022 in “ SAGE open medical case reports ”

Adrienn N. Bourkas, Cathryn Sibbald

upadacitinib alopecia areata atopic dermatitis Janus kinase 1 inhibitor topical corticosteroids spironolactone

TLDR Upadacitinib successfully treated a child's severe skin and hair loss issues.

This case report details the first successful use of the Janus kinase 1 inhibitor upadacitinib to treat alopecia areata and severe atopic dermatitis in a pediatric patient. The patient showed minimal response to topical corticosteroids and spironolactone, but significant improvements in hair growth on the scalp and body were observed after just 6 weeks of upadacitinib treatment.

View this study on journals.sagepub.com →

Discuss this study in the Community →

Cited in this study

5 / 5 results

research The JAK/STAT Signaling Pathway: From Bench to Clinic

489 citations , November 2021 in “Signal Transduction and Targeted Therapy”

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

research A Comprehensive Literature Review of JAK Inhibitors in the Treatment of Alopecia Areata

40 citations , June 2021 in “Clinical, cosmetic and investigational dermatology”

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

research Targeting the Janus Kinase Family in Autoimmune Skin Diseases

124 citations , October 2019 in “Frontiers in Immunology”

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

research JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis

130 citations , April 2019 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

research JAK Inhibitors in Dermatology: The Promise of a New Drug Class

355 citations , April 2017 in “Journal of the American Academy of Dermatology”

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

1 / 1 results

research Effectivity of Minoxidil as a Treatment for Alopecia Areata

January 2014 in “DOAJ (DOAJ: Directory of Open Access Journals)”